Logo (Actavis) 155 (Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base))
Pill with imprint Logo (Actavis) 155 is White, Round and has been identified as Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base). It is supplied by Actavis Elizabeth LLC.
Buprenorphine/naloxone is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 8 mg (base) / 2 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).
Images for Logo (Actavis) 155
Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual)
- Imprint
- Logo (Actavis) 155
- Strength
- 8 mg (base) / 2 mg (base)
- Color
- White
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Narcotic analgesic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 3 - Moderate abuse potential
- Labeler / Supplier
- Actavis Elizabeth LLC
- National Drug Code (NDC)
- 00228-3155
- Inactive Ingredients
-
citric acid anhydrous,
lactose monohydrate,
magnesium stearate,
mannitol,
corn starch,
povidone k30,
trisodium citrate dihydrate,
sucralose
Note: Inactive ingredients may vary.
More about buprenorphine / naloxone
- Side Effects
- During Pregnancy
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 1001 Reviews
- Drug class: narcotic analgesic combinations
- FDA Alerts (1)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.